medRxiv PreprintsInternational18 November 2026
Timing the Target: Exploring the Circadian Transcriptome of Biologic Therapies in Asthma.
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: Many of the immune pathways involved in asthma or in asthma treatment show circadian or diurnal variation. Understanding this variation can aid in biomarker discovery and/or therapy optimization. Objective: To evaluate if receptors, cytokines, and their pathways (n=46) targeted by currently approved biologics show significant diurnal rhythmicity and to identify their peak expression time. Methods: We used longitudinal bulk RNA sequencing datasets (discovery/replication cohorts: GSE113883 and GSE223613) and one microarray file (GSE39445) for cross-platform replication/validation. Fi
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.